This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SPDR® S&P Biotech ETF Receives Settlement Payment

State Street Global Advisors announced today that the SPDR® S&P Biotech ETF (NYSE: XBI- News) received payment as an authorized claimant from a class action settlement related to Dendreon, Corp.

The total amount payable to the Fund is listed below. When the Fund calculates its net asset value (“NAV”) per share on Tuesday, August 19, 2014, it is estimated that the Fund’s NAV will be impacted by the receipt of the payment in the amount stated below based on the shares outstanding as of August 15, 2014.

Fund    

Settlement Payment

   

Shares Outstanding as of August 15, 2014

    Per Share Amount
SPDR® S&P Biotech ETF     $233,312     7,500,000     $0.0311

Source: State Street Bank and Trust Co.

State Street Global Advisors manages more than $413 billion* in SPDR ETF assets worldwide (as of June 30, 2014) and is one of the largest ETF providers in the US and globally.

About State Street Global Advisors

State Street Global Advisors (SSGA) is a global leader in asset management. The firm is relied on by sophisticated investors worldwide for its disciplined investment process, powerful global investment platform and access to every major asset class, capitalization range and style. SSGA is the asset management business of State Street Corporation, one of the world’s leading providers of financial services to institutional investors.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs